IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that the company will present at ABGSC Investor Days in Stockholm on Thursday, May 23.
IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that the company will present at ABGSC Investor Days in Stockholm on Thursday, May 23.